Cargando…

Response: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)

Detalles Bibliográficos
Autores principales:	Choe, EunYeong, Kang, Eun Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2014
Materias:	Response
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160587/ https://www.ncbi.nlm.nih.gov/pubmed/25215280 http://dx.doi.org/10.4093/dmj.2014.38.4.319

Ejemplares similares

Letter: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
por: Lee, Seung-Hwan
Publicado: (2014)

Response: Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance (Diabetes Metab J 2014;38:143-9)
por: Esteghamati, Alireza, et al.
Publicado: (2014)

Response: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)
por: Hong, Jun Hwa, et al.
Publicado: (2015)

Response: Genome-Wide Association Study Identifies Two Novel Loci with Sex-Specific Effects for Type 2 Diabetes Mellitus and Glycemic Traits in a Korean Population (Diabetes Metab J 2014;38:375-87)
por: Go, Min Jin, et al.
Publicado: (2014)

Letter: Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance (Diabetes Metab J 2014;38:143-9)
por: Choi, Sung Hee
Publicado: (2014)

Letter: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)
por: Koo, Bo Kyung
Publicado: (2015)

Response: Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports (Diabetes Metab J 2020;44:349–53)
por: Kim, Na-young, et al.
Publicado: (2020)

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
por: Rhee, Sang Youl
Publicado: (2021)

Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)
por: Kim, Soon Ae, et al.
Publicado: (2011)

Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38)
por: Chung, Goh Eun, et al.
Publicado: (2020)

Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38)
por: Chung, Goh Eun, et al.
Publicado: (2020)

Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Response: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2013;37:262-9)
por: Yun, Jae-Seung, et al.
Publicado: (2013)

Response: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J 2013;37:423-8)
por: Kim, Jin Hwa, et al.
Publicado: (2014)

Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42)
por: Jin, Heung Yong, et al.
Publicado: (2021)

Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
por: Moon, Seong-Su, et al.
Publicado: (2021)

Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
por: Jung, Inha, et al.
Publicado: (2021)

Response: Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults (Diabetes Metab J 2020;44:592-601)
por: Rhee, Eun-Jung, et al.
Publicado: (2020)

Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study (Diabetes Metab J 2020;44:737–46)
por: Moon, Sun Joon, et al.
Publicado: (2020)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Kwang Joon, et al.
Publicado: (2013)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Song, Sun Ok, et al.
Publicado: (2012)

Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
por: Kang, Yang Ho
Publicado: (2016)

Response: Association between Diabetic Polyneuropathy and Chronic Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)
por: Chung, Jin Ook, et al.
Publicado: (2011)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
por: Baek, Jong Ha, et al.
Publicado: (2021)

Response: Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction? (Diabetes Metab J 2019;43:785–93)
por: Göbl, Christian S., et al.
Publicado: (2020)

Response: Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea (Diabetes Metab J 2012;36:151-6)
por: Kim, Hong-Kyu, et al.
Publicado: (2012)

Response: Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults (Diabetes Metab J 2011;35:551-7)
por: Oh, Hyung Geun, et al.
Publicado: (2012)

Response: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
por: Yun, Jae-Seung, et al.
Publicado: (2016)

Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
por: Park, Sejeong, et al.
Publicado: (2016)

Response: Patient Understanding of Hypoglycemia in Tertiary Referral Centers (Diabetes Metab J 2018;42:43-52)
por: Cho, Nan Hee, et al.
Publicado: (2018)

Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)
por: Lee, Chan-Hee
Publicado: (2021)

Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)
por: Chae, Jiun, et al.
Publicado: (2022)

Response: Balsamic Vinegar Improves High Fat-Induced Beta Cell Dysfunction via Beta Cell ABCA1 (Diabetes Metab J 2012;36:275-9)
por: Seok, Hannah, et al.
Publicado: (2012)

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
por: Kim, Sung-Tae, et al.
Publicado: (2011)

Response: Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93)
por: Yun, Jae-Seung, et al.
Publicado: (2017)

Response: Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes (Diabetes Metab J 2012;36:70-6)
por: Rajendran, Amarabalan, et al.
Publicado: (2012)

Response: Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus (Diabetes Metab J 2017;41:457-65)
por: Jeon, Eon Ju, et al.
Publicado: (2018)

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)
por: Zhang, Tianqi, et al.
Publicado: (2022)

Response: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307)
por: Ha, Jun Ouk, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ss4vungh97d2danihehra7opfb